-
2025-520843-34-00
Opioid Use Disorder 4
-
2023-504547-14-01
Reversible cerebral vasoconstriction syndrome 6
-
2024-519700-28-01
Patients with relapsing-remitting multiple sclerosis wi 4
-
2025-520850-13-00
Ischemic Stroke 4
-
2025-524296-23-01
Parkinsons Disease 6
-
2024-511790-30-00
Cervicobrachial Neuralgia 5
-
2024-519133-29-00
Focal epilepsy 4
-
2023-507715-35-02
Patients suffering from neurodegenerative diseases: Amy 4
-
2025-522692-29-00
Subacute Moderate to Severe Traumatic Brain Injury (TBI 4
-
2024-516701-22-00
Reduction of SystemiC Inflammation after ischemic strok 4
-
2024-519723-20-01
Glioma 9
-
2025-520887-17-00
Post-traumatic brain contusion with edema 6
-
2025-522697-37-00
Amyotrophic Lateral Sclerosis 7
-
2025-524316-11-00
Primary Progressive Multiple Sclerosis (PPMS) 5
-
2025-521512-20-00
PARKINSON’S DISEASE WITH MOTOR FLUCTUATIONS 5
-
2025-524317-88-00
Multiple System Atrophy 4
-
2025-523481-24-00
Participants with Progressive Supranuclear Palsy Richar 5
-
2024-515448-22-00
Parkinson 4
-
2024-518147-37-00
Stroke 4
-
2025-524343-13-00
Leber's Hereditary Optic Neuropathy 4
-
2024-516721-31-00
Non-24 Hour Sleep-Wake Disorder 5
-
2025-521529-34-00
chronic cluster headache 5
-
2024-513676-18-00
Transthyretin Amyloidosis 5
-
2024-517187-36-01
Dominantly Inherited Alzheimer’s Disease (DIAD) 10